These data suggest that the enhanced tumor growth in Dnase1l3-deficient mice might be a result of impaired DC function and consequent reduction in cytotoxic CD8+ and CD4+ T cells in dLNs and tumors. The gene discussed is CD8A; the disease is neoplasm.